Research

TIMM 2025 – Aspergillosis-Relevant Highlights for Non-Specialist Professionals

BRIEFING: Key…

🧪 Why New Antifungal Trials Start with Invasive Aspergillosis

When you hear about promising…

🩺 Why New Antifungal Medicines Aren’t for Everyone (Yet)

When new medicines are…

🌿 New Antifungal Medicines on the Horizon: Olorofim and Fosmanogepix

For many years, doctors have…

Understanding Risk from Aspergillosis — and What’s Improving

🧫 How risky is……

🫁 Understanding Chronic Cough in Aspergillosis

What the latest British…

🧬 Article 2: When Microbes Turn Hostile – The Evolutionary Pressures Behind Infection

Subtitle: Why stable…

🧬 From Scottish Discovery to American Pharmacy Shelf: The Story of Brensocatib

Sometimes a medicine begins…

🧩 NAC Aspergillosis Research Digest Aspergillosis (October 2025: week 44)

Highlights Pulmonary…

🌬️ Inhaled Antifungal Treatments for Chronic Pulmonary Aspergillosis (CPA)

Updated: October 2025 💡 Why…